Researchers at Washington University School of Medicine in St. Louis found that gene therapy in mice helped build strength and significant muscle mass quickly, while reducing the severity of osteoarthritis. The gene therapy also prevented obesity, even when the mice were fed a high-fat diet.
Exercise and physical therapy often are recommended to help people who have arthritis. Both can strengthen muscle — a benefit that also can reduce joint pain. But building muscle mass and strength can take many months and be difficult in the face of joint pain from osteoarthritis, particularly for older people who are overweight.
A new study in mice at Washington University School of Medicine in St. Louis, however, suggests gene therapy one day may help those patients.
The research shows that gene therapy helped build significant muscle mass quickly and reduced the severity of osteoarthritis in the mice, even though they didn’t exercise more. The therapy also staved off obesity, even when the mice ate an extremely high-fat diet.
The study is published online May 8 in the journal Science Advances.
“Obesity is the most common risk factor for osteoarthritis,” said senior investigator Farshid Guilak, PhD, the Mildred B. Simon Research Professor of Orthopaedic Surgery and director of research at Shriners Hospitals for Children — St. Louis. “Being overweight can hinder a person’s ability to exercise and benefit fully from physical therapy. We’ve identified here a way to use gene therapy to build muscle quickly. It had a profound effect in the mice and kept their weight in check, suggesting a similar approach may be effective against arthritis, particularly in cases of morbid obesity.”
With the paper’s first author, Ruhang Tang, PhD, a senior scientist in Guilak’s laboratory, Guilak and his research team gave 8-week-old mice a single injection each of a virus carrying a gene called follistatin. The gene works to block the activity of a protein in muscle that keeps muscle growth in check. This enabled the mice to gain significant muscle mass without exercising more than usual.
Even without additional exercise, and while continuing to eat a high-fat diet, the muscle mass of these “super mice” more than doubled, and their strength nearly doubled, too. The mice also had less cartilage damage related to osteoarthritis, lower numbers of inflammatory cells and proteins in their joints, fewer metabolic problems, and healthier hearts and blood vessels than littermates that did not receive the gene therapy. The mice also were significantly less sensitive to pain.
One worry was that some of the muscle growth prompted by the gene therapy might turn out to be harmful. The heart, for example, is a muscle, and a condition called cardiac hypertrophy, in which the heart’s walls thicken, is not a good thing. But in these mice, heart function actually improved, as did cardiovascular health in general.
Longer-term studies will be needed to determine the safety of this type of gene therapy. But, if safe, the strategy could be particularly beneficial for patients with conditions such as muscular dystrophy that make it difficult to build new muscle.
In the meantime, Guilak, who also co-directs the Washington University Center for Regenerative Medicine and is a professor of biomedical engineering and of developmental biology, said more traditional methods of muscle strengthening, such as lifting weights or physical therapy, remain the first line of treatment for patients with osteoarthritis.
“Something like this could take years to develop, but we’re excited about its prospects for reducing joint damage related to osteoarthritis, as well as possibly being useful in extreme cases of obesity,” he said.
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
- Gene Therapy: Go 'head, admit it, Thanksgiving stunkon November 28, 2020 at 4:30 am
It was unthinkable. That Thanksgiving stunk. This Thanksgiving stunk. But there will be great and wondrous Thanksgivings again. There have to be. Gene Collier: [email protected] and Twitter ...
- Researchers partner with faith leaders to promote gene therapy in communities of coloron November 27, 2020 at 7:46 am
A group of faith leaders and research scientists have partnered to create a nonprofit organization called The Faith Based Genetic Research Institute in a bid to promote the value of gene therapy in ...
- Latest spinoff from UNC’s Gene Therapy Center wants to find a cure for hemophilia | Raleigh News & Observeron November 27, 2020 at 5:08 am
UNC’s Gene Therapy Center has been prolific in generating startups in recent years. Its latest focuses on the rare blood disorder hemophilia.
- Global Gene Therapy Market Report 2020-2027: Market is Projected to Reach a Revised $3.3 Billionon November 27, 2020 at 2:18 am
Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. In a Major Setback to the Healthcare System, Non-COVID-19 Care Delivery Bears the Brunt of the ...
- Gene therapy may help prevent vision loss from genetic eye diseaseon November 26, 2020 at 9:15 pm
Researchers in Ireland have developed a new gene therapy treatment that may be able to save the vision of patients with a genetic disease that can lead to blindness. The condition, known as dominant ...
Go deeper with Google Headlines on:
Go deeper with Bing News on:
Gene therapy for osteoarthritis and obesity
- DARPA and JPEO Award Contract to SmartPharm, a Subsidiary of Sorrento, for Development of Rapid ...on November 28, 2020 at 3:50 am
STI-2020-encoded Gene MAb is in development for intramuscular injection against the SARS-CoV-2 virus and its variant strains to produce potent STI-2020 nAbs in the body. STI-2020-encoded Gene MAb ...
- Arthritis symptoms: Hard and knobbly fingers are linked to osteoarthritison November 25, 2020 at 7:03 am
ARTHRITIS can affect any joint in the body. However, take a look at your hand. Are your fingertips hard or knobbly? This could be a sign of osteoarthritis.
- The South & Central America cartilage degeneration market is expected to reach US$ 1,195.57 million by 2027 from US$ 959.32 million in 2019on November 24, 2020 at 7:30 am
The South & Central America cartilage degeneration market is expected to reach US$ 1,195.57 million by 2027 from US$ 959.32 million in ...
- Osteoarthritis Drugs Market: Anti-Nerve Growth Therapy Promises a New Avenue for Growthon November 19, 2020 at 11:37 pm
The global osteoarthritis drugs market is witnessing various innovations on the horizons such as rapid pain relieving injections and disease modifying drugs, thanks to growing cases of major illnesses ...
- As Obesity Soars, a Mayo Clinic DNA Study May Have Cracked The Causeon November 18, 2020 at 11:31 am
Called phenotyping, this bespoke mapping of each human on a subcellular level has allowed Acosta to create four different phenotype buckets that encompass 85% of all people suffering from obesity.